EIR TEVA Pharmaceuticals USA Apr 2000

Douglas Kovacs FDA$595.00 - Available Now

FDA investigators audited the TEVA Pharmaceuticals USA - Elmwood Park, NJ, United States facility and issued inspectional observation (via FDA 483) on 26 Apr 2000.

Product details

  • Category:
  • Inspection end: 26 Apr 2000
  • Location: Elmwood Park, United States
  • FEI: 2215768
Add To Cart